Stocky turns companies like KOHJIN BIO CO LTD into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Avoid. 177A.T scores poorly across growth (32.8) and value (38) metrics, signaling neither accelerating revenue nor attractive valuation. Leadership Alignment (36.3) is weak, indicating misalignment between insider incentives and shareholder interests. Though the Vulnerability Index shows no immediate structural risks, the combination of mediocre fundamentals and governance concerns makes this an unattractive opportunity.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for KOHJIN BIO CO LTD:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 29/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates KOHJIN BIO CO LTD (177A.T) at 29/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. 177A.T scores poorly across growth (32.8) and value (38) metrics, signaling neither accelerating revenue nor attractive valuation. Leadership Alignment (36.3) is weak, indicating misalignment between insider incentives and shareholde
177A.T's current Stocky Verdict is 29/100, placing it in the "Avoid" band. This composite combines a 38/100 Compounder score, 36/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for KOHJIN BIO CO LTD yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
KOHJIN BIO CO LTD scores 36/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
KOHJIN BIO CO LTD's Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to KOHJIN BIO CO LTD.
Sign up free and unlock the full analysis on 177A.T — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 177A.T in the app.
